Boston Scientific Corp - Company Profile
Powered by
All the data and insights you need on Boston Scientific Corp in one report.
- Save hours of research time and resources with
our up-to-date Boston Scientific Corp Strategy Report
- Understand Boston Scientific Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreBoston Scientific Corp (Boston Scientific) is a medical technology company that develops, manufactures and commercializes devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology and vascular surgery. Boston Scientific serves hospitals, clinics, outpatient facilities and medical offices across the world. The company has manufacturing facilities in the US, Ireland, Costa Rica, Brazil, Malaysia and Puerto Rico. It sells products directly and also through a network of distributors and dealers in Europe, the Middle East, Africa, Asia Pacific and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.
Boston Scientific Corp premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Gynecology Products | Endotak Reliance |
Pulmonology Products | Contak Renewal |
Electrophysiology Products | Confient |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Regulatory Approval | In March, the company secured approval from the U.S. Food and Drug Administration for the AGENT Drug-Coated Balloon. |
2024 | Contracts/Agreements | In March, the company extended its collaboration with Scivita Medical Technology Co., Ltd. for co-development and global distribution activities. |
2024 | Regulatory Approval | In February, the company secured approval from the U.S. Food and Drug Administration for an expanded indication of the WaveWriter SCS Systems to treat patients with chronic low back and leg pain. |
Competitor Comparison
Key Parameters | Boston Scientific Corp | Johnson & Johnson | Abbott Laboratories | Medtronic Plc | Nevro Corp |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | Ireland | United States of America |
City | Marlborough | New Brunswick | Abbott Park | Dublin | Redwood City |
State/Province | Massachusetts | New Jersey | Illinois | - | California |
No. of Employees | 48,000 | 131,900 | 114,000 | 95,000 | 1,215 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Michael F. Mahoney | Chairman; Chief Executive Officer; President | Executive Board | 2016 | 58 |
Daniel J. Brennan | Chief Financial Officer; Executive Vice President | Senior Management | 2014 | 57 |
Mary Beth Moynihan | Chief Marketing Officer; Senior Vice President - Market Access | Senior Management | 2021 | - |
Ian T. Meredith | Chief Medical Officer; Executive Vice President | Senior Management | 2017 | 66 |
Kenneth Stein | Senior Vice President; Chief Medical Officer - Global | Senior Management | 2023 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer